首页基础医学药理学药理学 01 药理学 绪论.ppt

01 药理学 绪论.ppt

页数:16页文件大小:1.08 MB来源: 药理学ppt课件

本课件为药理学课程中的《药理学总论-绪言》,围绕药理学总论-绪言、What is a drug、A goal of、One exampl等部分展开,逐页梳理概念、机制与临床应用要点,适合预习、课堂对照与考前复习。

药理学总论-绪言封面页,标示本课件的主题与What is a drug、A goal of、One example等内容。
What is a drug?,属「药理学总论-绪言」部分的内容页,讲解该节核心要点。
Sources of Drugs,Animals Plants Minerals Synthetic Microbes Genetic engineering drugs。
查看本课件的文字版(共 16 页,供检索与复制)

第1页:药理学总论-绪言

药理学总论-绪言 Pharmacology A Very Basic Intro

第2页:What is a drug?

What is a drug?-any chemical agent whichaffects any biological process

第3页:Sources of Drugs

Sources of Drugs Animals Plants Minerals Synthetic Microbes Genetic engineering drugs

第4页:

第5页:

第6页:A goal of Genomics

A goal of Genomics is to find and expressgenes that code for unknown peptides withsignificant biological properties, like receptorsor enzymes. In a reverse Pharmacologyapproach this peptide, e.g. a receptor, is thenused to "fish" for a natural ligand . Withreceptor and ligand in hand the biological roleof the receptor needs to be determined. Finally,screening for synthetic ligands as well as leadoptimization can lead to new drug candidates. In contrast, the classical approach to drugdiscovery starts with the identification of aligand that has biological activity that in turn isused to "fish" for the corresponding receptor.

第7页:One example for a

One example for a Genomics strategy aims atidentifying drug targets based on molecularhomology within Gene-families. One of the mostimportant families of drug-targets for thepharmaceutical industry is the family of G-proteincoupled receptors (GPCRs). Of the top 200 bestselling prescription drugs, more than 20%interact with GPCRs, providing worldwide sales ofover $20 billion. The characteristic motif of the GPCR family is the seven distinct hydrophobicregions, each of 20 to 30 amino acids that formthe transmembrane domain of these integralmembrane proteins. This key amino-acidsequence motif can be found within all types of GPCRs and can be used to identify DNA-sequences that code for GPCRs.

第8页:What is pharmacology

What is pharmacology ?-the study ofhowdrugseffect biological systems

第9页:What is Pharmacology

What is Pharmacology ?Pharmacology Pharmacokinetics Pharmacodynamics What the body does to drug What the drug does to body Pharmacotherapeutics Pharmacocognosy The study of the use of drugs Identifying crude materials as drugs Toxicology

第10页:Pharmacokinetics

  • Pharmacokinetics What the body does to the drug
  • Absorption
  • Distribution
  • Metabolism (Biotransformation)
  • Excretion Half-life (t1/2)-the time required for the plasmaconcentration of a drug to be reduced by 50 %

第11页:DRUG CLASSIFICATION

  • DRUG CLASSIFICATION
  • Based on the chemical structure
  • Based on the main effect (e.g.analgesics).
  • Based on the therapeutic use (e.g.antipsychotic 安定药).
  • Based on mechanism of action (e.g.serotonin agonist).

第12页:From Chemistto First

From Chemistto First In Man…approximately 7–10 years How a Drug becomes a drug…

第13页:H. Haarmann Universi

H. Haarmann University of Maryland, 2002Basic & Clinical Evaluation of New Drugs1. Drug discovery & Drug screening Chemistry In Vitro Studies Function in cells, tissues, and at receptors2. Preclinical safety & toxicity testing In Vivo

Animal studies Pharmacology and Behavioral Pharmacology Potency and Efficacy–ED50Toleranceand Tachyphylaxis(快速耐受) Toxicity–Acute and Chronic LD50Teratogenicity = birth defects Carcinogenicity = cancerous3. Evaluation of drug in humans

第14页:Evaluating Drugs in

Evaluating Drugs in Humans The Food and Drug Administration (FDA) Phases of a Clinical Trials Phase IPhase IIPhase IIIPhase IV

第15页:Evaluating Drugs in

  • Evaluating Drugs in Humans Phase I–Healthy adult volunteers
  • Evaluation of safety, Pharmacokinetics (PK), side effects???Phase II
  • Patients
  • Evaluation of efficacy, safety, PK, and side effects
  • Double-blind placebo controlled Phase III–Specific patient subpopulations
  • Determine efficacy for specific indications
  • Large sample of specific patients (1,000)
  • Randomized double-blind placebo controlled Phase IV–Post FDA Approval
  • Determine efficacy for specific indication
  • Determine drug utilization patterns and additional efficacy
  • Monitor rare, severe side effects/toxicity

第16页:Drug Nomenclature

Drug Nomenclature

Chemical name(化学名)-*Generic name(非专利名)

Trade name(商品名)Chemical Name: 2-(4-isobutylphenyl)-propionic acid Generic Name: ibuprofen(布洛芬)Trade Names: Advil, Aches-N

Pain, Brufen, Emodin, Haltran, Medipren, Midol 200, Motrin, Nuprin, Rufen, Trendar, Wal

Profen*preclinical nomenclature = company abbrev-123456 (e.g. WAY-100635, MK-869)

《药理学》课件目录

顶部目录